Etid klinik pou Obèsite nan Rhode Island
19 etid pou Obèsite ap chèche patisipan nan sit nan Rhode Island.
Vil nan Rhode Island
Tèks ofisyèl etid la (Anglè)
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07720271AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
- Clinical Res Collaborative, Cumberland
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 24, 2026 · NCT07339423Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- University Gastroenterology, Providence
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- University Gastroenterology, Providence
Ap rekriteFaz 3
Laj 18 a 70 · Tout sèks · Mizajou Sep 24, 2026 · NCT06937086Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Velocity Clinical Research - Providence, East Greenwich
Ap rekriteFaz 3
Laj 45 a 99 · Tout sèks · Mizajou Sep 22, 2026 · NCT07037433Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684235Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Velocity Clinical Research - Providence, East Greenwich
Ap rekriteFaz 3
Laj 18 a 99 · Tout sèks · Mizajou Sep 3, 2026 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, East Greenwich
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT07284901Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, East Greenwich
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT07284979Cognitive Strategies for Weight Loss
- Weight Control & Diabetes Research Center, Providence
Ap rekriteVolontè an sante akeyi
Laj 18 a 70 · Tout sèks · Mizajou Jul 15, 2026 · NCT05799846Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
- Women and Infants Hospital of Rhode Island, Providence
Ap rekrite
Laj 18 a 45 · Fanm · Mizajou Jun 24, 2026 · NCT05124808Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
- Brown University, Providence
Ap rekrite
Laj 21 ak plis · Tout sèks · Mizajou May 18, 2026 · NCT06948058Brain and Behavior Influences on Obesity Development From Infancy Through Childhood
- Rhode Island Hospital, Providence
Ap rekriteVolontè an sante akeyi
Laj 7 a 12 · Tout sèks · Mizajou May 7, 2026 · NCT06861868Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approaches in Behavioral Obesity Treatment
- The Weight Control and Diabetes Research Center of The Miriam Hospital & Brown University, Providence
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Feb 4, 2026 · NCT07228130Pilot Test of Five Weight Neutral Interventions to Improve Health Among Adults of Higher Body Weight
- Weight Control and Diabetes Research Center, Providence
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jan 23, 2026 · NCT07363616Weight Management Intervention in College: A Pilot
- The Miriam Hospital, Providence
Ap rekrite
Laj 18 a 29 · Tout sèks · Mizajou Oct 1, 2025 · NCT06994923Remote Approaches for Optimizing Weight Loss (Elevate Weight Loss Trial)
- The Miriam Hospital's Weight Control and Diabetes Research Center, Providence
Ap rekriteVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Mar 18, 2025 · NCT06875622Optimizing an Online Behavioral Weight Loss Intervention and Novel Culturally Tailored Components for Sexual Minority Women
- Weight Control and Diabetes Research Center, Providence
Ap rekrite
Laj 18 a 70 · Fanm · Mizajou Dec 27, 2024 · NCT05775497Control Systems Engineering for Weight Loss Maintenance
- Miriam Hospital Weight Control and Diabetes Resarch Center, Providence
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Apr 2, 2024 · NCT06244888Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.